Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
about
Receptor complexes for each of the Class 3 SemaphorinsSemaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeletonA perspective on the role of class III semaphorin signaling in central nervous system traumaIn-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image GliomaSemaphorin signaling in angiogenesis, lymphangiogenesis and cancerThe role of semaphorins and their receptors in gliomasMitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR ImagingOverexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection.Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models.PPAR-γ promotes endothelial cell migration by inducing the expression of Sema3g.Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis
P2860
Q21129485-6367CC94-ED8D-4367-86AC-B0C268DDF7FFQ24307909-59D57740-344B-464E-B10C-70CA68BCCBB6Q28251368-D6D79EE4-2980-43AB-9DE2-CBCE5131EC85Q33525762-8F2F5671-EDAF-4B66-88AD-2545936242A2Q34227556-9CAE6A2B-C9D6-4F61-BC1B-99981419DD85Q35785243-53FAB925-2EBE-4C4A-BD24-1BD5C6411F42Q35958869-0B7B2773-5EF1-46B4-A1E3-95C9A98A1053Q36289377-4AF06542-92F2-4745-8056-E0099A32065BQ36755234-FBDA11A3-391C-4F1A-8BD4-E86C25007D8BQ37588358-8B52B5CE-49A7-4309-83EB-6B1F28549AEEQ37713342-5778AED5-6EB5-4D00-A34A-C3E4E40F6D7AQ38256958-47CFAA2A-6893-4F2B-A6A2-AF004EC2D6F3Q38850720-7A60AF13-B9A8-4DCC-A30E-0358B0073123Q40817034-CDA55FF1-9DFC-4FD9-A7B1-7A16D9EEF1E8Q47128907-F4CA42E9-55ED-4974-B1DC-90B796B2AFE2Q51506379-2E2E29FE-555C-4E40-8371-966C2B16B8CDQ58569848-5795C98D-4DE6-4CC7-A0A1-5C597BB2CD80
P2860
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
@en
type
label
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
@en
prefLabel
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
@en
P2093
P2860
P356
P1476
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
@en
P2093
C Marquant
J Clarhaut
L Karayan-Tapon
P Levillain
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604641
P407
P577
2008-09-09T00:00:00Z
P5875
P6179
1036086188